Seattle breakthrough offers Spokane boy relief from rare hunger condition

A Spokane boy suffering from a rare condition causing constant hunger due to brain damage has found relief through a breakthrough treatment in Seattle. The condition, hypothalamic obesity, results from brain injury or tumors and leads to uncontrollable appetite. The drug Setmelanotide, recently approved by the FDA, has shown significant results in clinical trials, reducing BMI and alleviating symptoms. The boy's family reports he is now 'back to living life' after the treatment, which targets the underlying mechanism of the condition. This development offers hope for patients with acquired hypothalamic obesity, a previously difficult-to-treat disorder.